- N
Navitor Pharmaceuticals
- Vinzenz Ploerer
Vinzenz Ploerer is Brace Pharma Capital’s President and CEO, and sits on the Board of Directors. Vinzenz is a life science executive with 30+ years of extensive leadership experience in operations, acquisitions, and business development. Prior to launching Brace in 2013, he worked at EMS S/A as Senior Vice President of Strategy and Operations. He has also held multiple senior leadership positions at Novartis/Sandoz including country head of Brazil, Argentina and Head of BDL Sandoz, building the company through acquisitions. Vinzenz currently sits on several corporate boards including GeNO, Therabron, Tyrogenex, and Navitor.
Vinzenz received an MBA from the University of Innsbruck.
Org chart
This person is not in the org chart
Teams
Offices
This person is not in any offices
Navitor Pharmaceuticals
Navitor Pharmaceuticals is a biopharmaceutical company developing novel medicines by targeting cellular nutrient signaling pathways. The company’s proprietary drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth.
